Cetiedil

This classification denotes a vasodilating agent with the molecular formula C20H31NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 621RT200TO, chemically known as 3-thiopheneacetic acid, alpha-cyclohexyl-, 2-(hexahydro-1h-azepin-1-yl)ethyl ester but generally known as cetiedil, which bears US NIH Compound Identifier 66384. European Medicines Agency schedules Cetiedil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07450MIG. The term CETIEDIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules cetiedil in its Anatomical Therapeutic Chemical (ATC) Classification. CETIEDIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cetiedil under HS 29349990 and SITC 51579. As of Q4 2014, CETIEDIL remains the US FDA Preferred Term for this commodity. Cetiedil bears US NLM identifiers UMLS ID C0055146 and NCI Concept Code C79584. SMILES: s1cc(C(C2CCCCC2)C(=O)OCCN2CCCCCC2)cc1.